Biosimilar Molecules

Pfēnex is utilizing Pfēnex Expression Technology to build a comprehensive portfolio of Biosimilar molecules. Capitalizing on the cost effectiveness of Pfēnex Expression Technology based processes and the proven ability to rapidly identify a robust production strain, Pfēnex is rapidly becoming a leader in biosimilar development.

Pfēnex currently has three biosimilar molecules at an advanced stage of process development.  We are currently seeking co-development partners for these molecules and are seeking to partner on new biosimilar programs.